My guess is that in the conference call, will either announce another PIPE, or will present the details of the neurology division's assessment of the 6' box. I think the latter's the case, since my guess is that when cor sets up a PIPE the know the time-line well enough to give an exact date for the CC announcing it.
If Neurology explicitly states that cor has addressed the concern about the histology artifact, it is not clear to me what would stand in the way of Psychiatry approving the ADHD trial, since I don't know of other unresolved issues pertaining to CX-717.
Market Data 
Markets 
AI
